James Hunter
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
James Hunter is the founder of ReliaLAB, Inc. Current jobs include Director at Tonix Pharmaceuticals Holding Corp.
starting in 2025.
Former jobs include President & Chief Executive Officer at Validus Pharmaceuticals LLC from 2007 to 2018 and Executive Director-Northeast Business Unit at Ciba-Geigy Pharmaceuticals.
Education includes an MBA from Fairleigh Dickinson University and an undergraduate degree from Seton Hall University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Directeur/Membre du Conseil | 12/06/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Develops and markets psychiatry and neurology products | Directeur Général | 01/06/2018 |
Ciba-Geigy Pharmaceuticals | Corporate Officer/Principal | - |
ReliaLAB, Inc. | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
ReliaLAB, Inc. | |
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Develops and markets psychiatry and neurology products | Retail Trade |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba-Geigy Pharmaceuticals | |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national